Motley Fool: This Is the Top Marijuana Stock to Buy in September

You could rightly say that this has been a bipolar year for marijuana stock investors. It began with an incredible run that saw the Horizons Marijuana Life Sciences ETF, the first tradable cannabis ETF, gain more than 50% during the…

Advertisements

Motley Fool: Hedge Funds Absolutely Dumped Marijuana’s “Big Three” in the Second Quarter

For years, the marijuana industry has seemingly shown nothing but promise. For investors lucky enough to have bought into the “Big Three” of the cannabis world — Canopy Growth (NYSE:CGC), Aurora Cannabis (NYSE:ACB), and Cronos Group (NASDAQ:CRON) — at the beginning of…

Motley Fool: Is Tilray Finally a Buy?

Canada’s top pot producers have all seen their valuations shoot higher this year — that is, except Tilray (NASDAQ:TLRY). Over the first five months of the year, Tilray’s market cap has slipped by an unsightly 25%. Worse still, the company’s…

Motley Fool: Why Marijuana Stocks Tilray, Cronos, and New Age Beverages Fell 10% to 19% in March

What happened Shares of cannabis companies Tilray (NASDAQ:TLRY), Cronos Group (NASDAQ:CRON), and New Age Beverages (NASDAQ:NBEV) dropped 19.4%, 14.8%, and 10.4%, respectively, in March, according to data from S&P Global Market Intelligence. For context, the S&P 500 rose 1.9% last month. Those stocks have…

Motley Fool: 3 Reasons Legal Weed Sales Aren't Getting Any Higher in Canada

According to Health Canada, licensed businesses sold 7,115 kilograms of dried flower in January. That was 3.7% less than in December, which hardly looks like a Canadian sales explosion that will help Aurora Cannabis (NYSE:ACB) or Cronos Group (NASDAQ:CRON) make ends meet before…